Skip to main content
Premium Trial:

Request an Annual Quote

ABI Wraps Up $273M Acquisition of Ambion s RNA Business

NEW YORK, March 2 (GenomeWeb News) - Applied Biosystems has closed its acquisition of the research products division of Ambion.

 

The $273-million cash acquisition, which the firms announced in late December, enables ABI to enter the consumables market for sample prep, RNAi, microRNA, and gene-expression and array products.

 

The market in which this business plays is believed to be around $500 million market and grows more than 10 percent annually, according to ABI.

 

The research products division has about 300 employees, and will continue to be based in Austin. It will report to ABI's molecular biology division.

 

According to ABI, Ambion stands to generate more than $52 million in revenue in 2005, which would be a 22-percent improvement over last year's receipts.

The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.